Treatment of HER2-Positive Metastatic Breast Cancer Following Initial Progression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of HER2-Positive Metastatic Breast Cancer Following Initial Progression

Published:2009-06 Issue: Volume:9 Page:S50-S57
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Mayer Ingrid A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference99 articles.

1. Survival of premenopausal women with metastatic breast cancer: long-term follow-up of Eastern Cooperative Group and Cancer and Leukemia Group B studies;Falkson;Cancer,1990

2. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer;Greenberg;J Clin Oncol,1996

3. The value of estrogen and progesterone receptors in the treatment of breast cancer;Osborne;Cancer,1980

4. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

5. The neu oncogene: an erb-Brelated gene encoding a 185,000-Mr tumour antigen;Schechter;Nature,1984

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Signature Based on Angiogenesis-Related Genes Predicts the Prognosis and Immunotherapy Response in HER2-Positive Breast Cancer;Journal of Cancer;2024

2. HER2 Activation and Endocrine Treatment Resistance in HER2-negative Breast Cancer;Endocrinology;2021-07-28

3. Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment;MedComm;2021-06-10

4. Direct stimulation of ERBB2 highlights a novel cytostatic signaling pathway driven by the receptor Thr701 phosphorylation;Scientific Reports;2020-10-09

5. Harnessing Natural Killer Cells’ Killing Function in Cancer;Second Generation Cell and Gene-based Therapies;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3